Spero Therapeutics (SPRO) FCF Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 621,697.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 621,697.00 |
| Dec 31, 2025 | 19,098.00 |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | 19,284.00 |
| Mar 31, 2025 | -13,221.00 |
| Dec 31, 2024 | -5,065.00 |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 36,597.00 |
| Mar 31, 2024 | 582,775.00 |
| Dec 31, 2023 | -29,186.00 |
| Sep 30, 2023 | 734,817.00 |
| Jun 30, 2023 | 47,219.00 |
| Mar 31, 2023 | -439,959.00 |
| Dec 31, 2022 | 44,202.00 |
| Sep 30, 2022 | 65,173.00 |
| Jun 30, 2022 | -36,904.00 |
| Mar 31, 2022 | -115,205.00 |
| Sep 30, 2021 | 5.54 Mn |
| Jun 30, 2021 | 65,579.00 |
| Mar 31, 2021 | 116,409.00 |
| Sep 30, 2020 | -5.59 Mn |
| Jun 30, 2020 | 1.67 Mn |
| Mar 31, 2020 | -123,354.00 |
| Dec 31, 2019 | -171,350.00 |
| Sep 30, 2019 | 62,959.00 |
| Jun 30, 2019 | -1.63 Mn |
| Dec 31, 2018 | 48,258.00 |
| Sep 30, 2018 | 92,331.00 |
| Jun 30, 2018 | 169,875.00 |
| Dec 31, 2017 | -1.58 Mn |